Voyager Therapeutics Inc

NASDAQ:VYGR  
6.94
-0.53 (-7.10%)
Earnings Announcements

Voyager Therapeutics Prioritizes Pipeline, Reports Second Quarter 2022 Financial Results

Published: 08/04/2022 20:58 GMT
Voyager Therapeutics Inc (VYGR) - Voyager Therapeutics Prioritizes Pipeline and Reports Second Quarter 2022 Financial and Operating Results.
Strong Balance Sheet and Disciplined Financial Approach Expected to Maintain Cash Runway Into 2024.
Strong Balance Sheet and Disciplined Financial Approach Expected to Maintain Cash Runway Into 2024.
Qtrly Net Loss per Share, Basic and Diluted $0.50.
Q2 Earnings per Share View $-0.32 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $6.65 Million
Adjusted EPS is expected to be -$0.43

Next Quarter Revenue Guidance is expected to be $8.97 Million
Next Quarter EPS Guidance is expected to be -$0.39

More details on our Analysts Page.